Novartis’ experimental cancer treatment wins endorsement of FDA advisers
The U.S. Food & Drug Administration (FDA) on Wednesday endorsed a first-of-its-kind cancer treatment that makes use of patients’ revved-up immune cells to fight back the deadly disease.
Advisers to the FDA recommended approval of a new experimental cancer treatment called CAR-T therapy for kids with leukemia. The new treatment retrains the patient’s immune system to kill tumor cells.
Oncologic Drugs Advisory Committee member Timothy Cripe, an oncologist with Nationwide Children’s Hospital in Ohio, said the recommendation for the treatment was the most exciting thing she had seen in her lifetime.
However, Dr. Wilson Bryan, who directs the agency’s office that oversees these kinds of treatments, said it would be difficult to standardize.
Commenting on the treatment, Dr. Bryan said, “Particularly, we are concerned that the same safety and benefit seen in clinical trials may not translate into routine use. This is a complex product.”
The recommendation from the federal agency’s Oncologic Drugs Advisory Committee indicates that Novartis’ experimental treatment can be approved by the agency by the end of September this year.
Following an unanticipated upturn in economic activity in September, the eurozone economy is widely expected to be on track for the best quarter since 2015.
Elon Musk-led electric carmaker Tesla Motors has confirmed that it will discontinue its cheapest version of its Model S e-car, the rear-wheel-drive S60, on coming Sunday.
Motorola’s parent firm Lenovo recently announced the launch of the Moto G5S and G5S Plus smartphones in several markets. The company will shortly share its plan for worldwide launch.
Luxury vehicle maker Volvo has just introduced the 2018 XC40, the company’s latest SUV that looks forward to compete with the Porsche Macan or Range Rover Evoque.
European Commission President Jean-Claude Juncker’s proposal to expand Eurozone by bringing more countries into it has triggered controversy, mainly in Germany, where Chancellor Angela Merkel is seeking re-election.
Wall Street soared to record highs on Friday, thanks to robust trading in telecommunication shares as well as bouncing back of technology shares after a couple of days of declines.